Oct 6, 2016 | By Tess
3D bioprinting is one of the most promising applications for additive manufacturing in the medical field, so it is no wonder that companies and organizations all over the world are trying to get ahead with developing the technology. Recently, Romania put itself on the 3D bioprinting map, as Timisoara-based tech startup Symme 3D introduced the country’s first ever 3D bioprinter.
The news of Romania’s first 3D bioprinter is exciting for the small nation as well as for Europe in general, as the new additive manufacturing system will be used in research conducted by the Center for Gene and Cellular Therapies in the Treatment of Cancer (OncoGen). The medical research center is one-of-a-kind both in Romania and largely in Southeastern Europe.
According to Calin Brandabur, founder and Chief Technology Officer of Symme 3D, OncoGen has already begun work with the new 3D bioprinter, using it to make samples of cartilage, and experimenting with the use of epithelial cells and stem cells. So far, they have even successfully bioprinted substantial but relatively simple cartilage tissues, such as for the ears and nose.
Brandabur also has high aspirations for his company’s 3D bioprinter, as he believes with further development it could be capable of printing blood vessels, beginning with large ones and eventually even smaller ones. The next step would then be to develop the technology to print more vascularized and complex human tissues, such as human skin. Ultimately, Brandabur hopes that Symme 3D will be able to advance their 3D bioprinter so it can even print organs, like the liver, kidneys, bones, and muscles. Of course, these types of results could be years off, but when achieved could present a low risk solution for implants, as the organs would be made from the patient’s own cells.
Currently, OngoGen has three 3D printers on its premises, including Symme 3D’s bioprinter, which are primarily helping in one of the center’s lines of research: regenerative medicine. OncoGen has also been exploring another application for the bioprinter with Symme 3D, which would use the printer for targeted and personalized treatments for such diseases as cancer.
Romania’s Center for Gene and Cellular Therapies in the Treatment of Cancer is reportedly planning to apply for additional funding from the EU in order to further their research and tests within the field of 3D bioprinting and 3D regeneration.
Symme 3D is also preparing for the release of their multifunctional delta platform, which consists of an integrated 3D printer, PCB router, and Laser etcher.
Images credit: Symme 3D
Posted in 3D Printer
Maybe you also like:
- Josef Prusa's MK2 set to enter the multi-color 3D printer race with a clever twist
- Airwolf 3D adds radical direct drive to create the complete dual extruder 3D printer
- Mattel postpones release of toy-making ThingMaker 3D printer until fall 2017
- Review: Layer One Atom 2.0 Delta 3D printer with swappable laser engraver is worth checking out
- Robo C2 and Robo R2 Smart 3D Printers launch on Kickstarter
- MakerBot gets an upgrade: New Replicator+ 3D printer promises bigger and faster 3D prints
- Zhuhai CTC Electronic launches Walnut 18 SLM metal 3D printer and Riverbase 500 industrial SLA 3D printer
- Create Orthotics and Prosthetics launches first ever all-in-one medical-grade 3D printer for prosthetics
- Lightning 3D double-exposure UV DLP 3D printer on Kickstarter for $1,900
This looks bloody awful. Romania, a country which puts real horses in the meaning horse power.
3Ders.org provides the latest news about 3D printing technology and 3D printers. We are now seven years old and have around 1.5 million unique visitors per month.
